APOB and early-onset autosomal dominant Alzheimer disease: In this study, we explored the association between an apoB polygenic instrument and self-reported outcomes in first-degree relatives in participants of the UK Biobank for 12 diseases (including heart disease, stroke, hypertension, and Alzheimer’s disease) and parental vital status together with age at death.